当前位置: 首页 > 期刊 > 《中国医学创新》 > 2025年第17期
编号:2390327
盐酸氨溴索联合哌拉西林钠他唑巴坦钠 对老年慢性阻塞性肺疾病急性加重期疗效的影响
http://www.100md.com 2025年8月14日 中国医学创新 2025年第17期
    

    Effect of Ambroxol Hydrochloride Combined with Piperacillin Sodium and Tazobactam Sodium on the Elderly Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease/YANG Qian, WANG Ting,LIANShuimei,KANGWeifang,WANGYongli.//Medical Innovation of China,2025,22(17): 057-060

    [Abstract] Objective: To investigate the therapeutic effect of Ambroxol Hydrochloride combined with Piperacillin Sodium and Tazobactam Sodium in elderly patients with acute exacerbationof chronic obstructive pulmonary disease (AECOPD).Method: A retrospective analysis was conducted on the data of 304 patients with AECOPD admitted to Nanping First Hospital from January 2O21 to January 2O24.They were divided into two groups according to diferent treatment methods,with 152cases in each group.Both groups received conventional treatment.The control group was treated with intravenous infusion of Piperacillin Sodiumand Tazobactam Sodium, while theobservation group was treated with Ambroxol Hydrochlorideonthe basis of thecontrol group.The clinical effcacy ......

您现在查看是摘要页,全文长 12843 字符